Shandong Anxin Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from EDQM.
One of their notable products is FOSAPREPITANT DIMEGLUMINE (NON-STERILE API), with a corresponding US DMF Number 33142.
Remarkably, this DMF maintains an Active status since its submission on November 30, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 29, 2019, and payment made on November 27, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II